Sign Up Today and Learn More About Reven Pharmaceuticals Stock
Invest in or calculate the value of your shares in Reven Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Reven Pharmaceuticals Stock (REVP)
Bio-Pharmaceutical Company
About Reven Pharmaceuticals Stock
Founded
1999
Headquarters
Golden, CO, US
Total Funding
62.3M
Industries
Software, Artificial Intelligence, Data and Analytics
Reven Pharmaceuticals Press Mentions
Stay in the know about the latest news on Reven Pharmaceuticals
Peripheral Artery Disease Global Market to Surpass USD 54 ...
prnewswire • Dec 27, 2023
Reven Announces the Appointment of Eminent Physician-Scientist Fatih M. Uckun, M.D. Ph.D., Internationally Recognized for his Seminal Contributions to Oncology, Immunology and Immunity, as its Chief Medical Officer and Chief Scientific Officer
Reven • Jun 26, 2020
Reven Pharmaceuticals Management
Leadership team at Reven Pharmaceuticals
Co-Founder & Chief Executive Officer
Peter Lange
Chief Financial Officer
Jeffrey Halverson
Join now and verify your accreditation status to gain access to:
- Reven Pharmaceuticals Current Valuation
- Reven Pharmaceuticals Stock Price
- Reven Pharmaceuticals Management
- Available deals in Reven Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Reven Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Reven Pharmaceuticals Revenue and Financials
- Reven Pharmaceuticals Highlights
- Reven Pharmaceuticals Business Model
- Reven Pharmaceuticals Risk Factors
- Reven Pharmaceuticals Research Report from SACRA Research
Trading Reven Pharmaceuticals Stock
How to invest in Reven Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Reven Pharmaceuticals through EquityZen funds. These investments are made available by existing Reven Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Reven Pharmaceuticals stock?
Shareholders can sell their Reven Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
